Transvenous electrical cardioversion of atrial fibrillation in horses: Horse and procedural factors correlated with success and recurrence

Abstract Background Transvenous electrical cardioversion (TVEC) is 1 of the main treatment options for atrial fibrillation (AF) in horses. Large‐scale studies on factors affecting success and prognosis have primarily been performed in Standardbred populations. Hypothesis/Objectives To determine fact...

Full description

Bibliographic Details
Main Authors: Ingrid Vernemmen, Glenn Van Steenkiste, Alexander Dufourni, Annelies Decloedt, Gunther vanLoon
Format: Article
Language:English
Published: Wiley 2022-03-01
Series:Journal of Veterinary Internal Medicine
Subjects:
Online Access:https://doi.org/10.1111/jvim.16395
_version_ 1818759133978951680
author Ingrid Vernemmen
Glenn Van Steenkiste
Alexander Dufourni
Annelies Decloedt
Gunther vanLoon
author_facet Ingrid Vernemmen
Glenn Van Steenkiste
Alexander Dufourni
Annelies Decloedt
Gunther vanLoon
author_sort Ingrid Vernemmen
collection DOAJ
description Abstract Background Transvenous electrical cardioversion (TVEC) is 1 of the main treatment options for atrial fibrillation (AF) in horses. Large‐scale studies on factors affecting success and prognosis have primarily been performed in Standardbred populations. Hypothesis/Objectives To determine factors affecting cardioversion success, cardioversion difficulty and recurrence in a predominant Warmblood study sample. Animals TVEC records of 199 horses. Methods Retrospective study of TVEC procedures of horses admitted for AF without severe echocardiographic abnormalities. Horse and procedural factors for success and cumulative amount of energy (≤ 600 J vs > 600 J) were determined using multivariable logistic regression. A survival analysis was performed to determine risk factors for recurrence. Results Two hundred and thirty‐one TVEC procedures were included, with a 94.4% success rate and 31.9% recurrence rate (51/160). Mitral regurgitation (OR 0.151, 95% CI 0.032‐0.715, P = .02) and AF cycle length (OR 1.05, 95% CI 1.01‐1.09, P = .02) were independent determinants for success. Catheter type (OR 0.154, 95% CI 0.074‐0.322, P < .001), previous AF episode (OR 3.10, 95% CI 1.20‐8.01, P = .02), tricuspid regurgitation (OR 2.54, 95% CI 1.25‐5.13, P = .01), and body weight (OR 1.009, 95% CI 1.003‐1.015, P = .004) were significantly correlated with cumulative amount of energy delivered. Significant risk factors for recurrence after a first AF episode were sex (stallion; HR 3.05, 95% CI 1.34‐6.95, P = .008), mitral regurgitation (HR 1.91, 95% CI 1.08‐3.38, P = .03), and AF duration (HR 1.001, 95% CI 1.0001‐1.0026, P = .04). Conclusions and Clinical Importance Both horse and procedural factors should be considered when assessing treatment options and prognosis in horses with AF.
first_indexed 2024-12-18T06:37:53Z
format Article
id doaj.art-800312e018184050aa167b34407c66cd
institution Directory Open Access Journal
issn 0891-6640
1939-1676
language English
last_indexed 2024-12-18T06:37:53Z
publishDate 2022-03-01
publisher Wiley
record_format Article
series Journal of Veterinary Internal Medicine
spelling doaj.art-800312e018184050aa167b34407c66cd2022-12-21T21:17:43ZengWileyJournal of Veterinary Internal Medicine0891-66401939-16762022-03-0136275876910.1111/jvim.16395Transvenous electrical cardioversion of atrial fibrillation in horses: Horse and procedural factors correlated with success and recurrenceIngrid Vernemmen0Glenn Van Steenkiste1Alexander Dufourni2Annelies Decloedt3Gunther vanLoon4Equine Cardioteam, Department of Large Animal Internal Medicine, Faculty of Veterinary Medicine Ghent University Merelbeke BelgiumEquine Cardioteam, Department of Large Animal Internal Medicine, Faculty of Veterinary Medicine Ghent University Merelbeke BelgiumEquine Cardioteam, Department of Large Animal Internal Medicine, Faculty of Veterinary Medicine Ghent University Merelbeke BelgiumEquine Cardioteam, Department of Large Animal Internal Medicine, Faculty of Veterinary Medicine Ghent University Merelbeke BelgiumEquine Cardioteam, Department of Large Animal Internal Medicine, Faculty of Veterinary Medicine Ghent University Merelbeke BelgiumAbstract Background Transvenous electrical cardioversion (TVEC) is 1 of the main treatment options for atrial fibrillation (AF) in horses. Large‐scale studies on factors affecting success and prognosis have primarily been performed in Standardbred populations. Hypothesis/Objectives To determine factors affecting cardioversion success, cardioversion difficulty and recurrence in a predominant Warmblood study sample. Animals TVEC records of 199 horses. Methods Retrospective study of TVEC procedures of horses admitted for AF without severe echocardiographic abnormalities. Horse and procedural factors for success and cumulative amount of energy (≤ 600 J vs > 600 J) were determined using multivariable logistic regression. A survival analysis was performed to determine risk factors for recurrence. Results Two hundred and thirty‐one TVEC procedures were included, with a 94.4% success rate and 31.9% recurrence rate (51/160). Mitral regurgitation (OR 0.151, 95% CI 0.032‐0.715, P = .02) and AF cycle length (OR 1.05, 95% CI 1.01‐1.09, P = .02) were independent determinants for success. Catheter type (OR 0.154, 95% CI 0.074‐0.322, P < .001), previous AF episode (OR 3.10, 95% CI 1.20‐8.01, P = .02), tricuspid regurgitation (OR 2.54, 95% CI 1.25‐5.13, P = .01), and body weight (OR 1.009, 95% CI 1.003‐1.015, P = .004) were significantly correlated with cumulative amount of energy delivered. Significant risk factors for recurrence after a first AF episode were sex (stallion; HR 3.05, 95% CI 1.34‐6.95, P = .008), mitral regurgitation (HR 1.91, 95% CI 1.08‐3.38, P = .03), and AF duration (HR 1.001, 95% CI 1.0001‐1.0026, P = .04). Conclusions and Clinical Importance Both horse and procedural factors should be considered when assessing treatment options and prognosis in horses with AF.https://doi.org/10.1111/jvim.16395amiodaronearrhythmiacardiologyequinesotalol
spellingShingle Ingrid Vernemmen
Glenn Van Steenkiste
Alexander Dufourni
Annelies Decloedt
Gunther vanLoon
Transvenous electrical cardioversion of atrial fibrillation in horses: Horse and procedural factors correlated with success and recurrence
Journal of Veterinary Internal Medicine
amiodarone
arrhythmia
cardiology
equine
sotalol
title Transvenous electrical cardioversion of atrial fibrillation in horses: Horse and procedural factors correlated with success and recurrence
title_full Transvenous electrical cardioversion of atrial fibrillation in horses: Horse and procedural factors correlated with success and recurrence
title_fullStr Transvenous electrical cardioversion of atrial fibrillation in horses: Horse and procedural factors correlated with success and recurrence
title_full_unstemmed Transvenous electrical cardioversion of atrial fibrillation in horses: Horse and procedural factors correlated with success and recurrence
title_short Transvenous electrical cardioversion of atrial fibrillation in horses: Horse and procedural factors correlated with success and recurrence
title_sort transvenous electrical cardioversion of atrial fibrillation in horses horse and procedural factors correlated with success and recurrence
topic amiodarone
arrhythmia
cardiology
equine
sotalol
url https://doi.org/10.1111/jvim.16395
work_keys_str_mv AT ingridvernemmen transvenouselectricalcardioversionofatrialfibrillationinhorseshorseandproceduralfactorscorrelatedwithsuccessandrecurrence
AT glennvansteenkiste transvenouselectricalcardioversionofatrialfibrillationinhorseshorseandproceduralfactorscorrelatedwithsuccessandrecurrence
AT alexanderdufourni transvenouselectricalcardioversionofatrialfibrillationinhorseshorseandproceduralfactorscorrelatedwithsuccessandrecurrence
AT anneliesdecloedt transvenouselectricalcardioversionofatrialfibrillationinhorseshorseandproceduralfactorscorrelatedwithsuccessandrecurrence
AT gunthervanloon transvenouselectricalcardioversionofatrialfibrillationinhorseshorseandproceduralfactorscorrelatedwithsuccessandrecurrence